Skin Models

HypoSkin services combine an ex vivo skin platform with new generation transcriptomic, cytokine analysis and bioinformatics to support your R&D with human insights.

The User Manual includes detailed descriptions of the HypoSkin^® model, available formats, and a step-by-step guide for kit use.

Top-level science through the eyes of an expert.The fifth Webinar. The fifth webinar in the Naked Immunology series is now scheduled on June 30, 2023 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Cezmi Akdis, the director of the Swiss Institute ofRead more

Human skin to better predict clinical trial outcomes Based on the Tech Nation interview with Dr. Eric Merle, our Chief Bussiness Innovation Officer by Moira Gunn, in February 2022. The entire Tech Nation Radio Podcast is available here. Eric's interview starts at 44:00 mins. Close is not good enough We've grown used to testing drugs in animals because some animalsRead more

Before proceeding to clinical trials in humans, today’s scientists study drug efficacy and toxicity in animals. Even though animal studies clearly raise ethical questions, it is considered even more unethical to conduct studies directly on humans without prior testing. Genoskin provides a unique alternative to animal testing and to human trials, using real, immunocompetent human skin. Why human skin isRead more

CREATING BETTER TECHNOLOGY FOR RELIABLE DRUG DEVELOPMENT STUDIES Changing drug development as we know it Genoskin aims to change drug development technology as we know it. We combine artificial intelligence and cutting-edge technology with live ex vivo human tissue to efficiently help pharmaceutical and biotech companies develop new drugs and vaccines in a better, faster and more cost-efficient way. AndRead more